New EU GMP guide tackles increasing use of computerised systems
This article was originally published in SRA
Executive Summary
The European Commission has revised certain sections of its current guideline on good manufacturing practice requirements for human drugs. The changes, which will come into effect on 30 June, have been made in response to the increasing use of electronic documents in the GMP environment1.